Northeast Georgia Health System Medical Staff Podcast
Hosted by Larry Dudas, MD and Dan Robinson, MD Guests for today's episode: Vijaya Ramalingam, MD, FCCP Pulmonary and Critical Care Physician, NGPG Program Director, Pulmonary and Critical Care Medicine Fellowship, NGMC Stefanie Kananda, DO Northeast Georgia Physicians Group Pulmonology Disclosures: None Claim CME Credit: https://www.surveymonkey.com/r/W88KJD3 [https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.surveymonkey.com%2Fr%2FW88KJD3&data=05%7C02%7CRobert.Morgan%40nghs.com%7Cf763b8ae9eb14233c2a408dec0b2c729%7C40b25b52baa94064b996386153e61e46%7C0%7C0%7C639160071258243413%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=VsluduR%2BYLDSBiP9%2BUKMT%2BxjXMRJ6dUFzoOPNmIFcjU%3D&reserved=0] Post Date: 6/1/26 Expiration Date: 6/1/28 Accreditation Statement: The Northeast Georgia Medical Center & Health System, Inc. is accredited by the Medical Association of Georgia to provide continuing medical education for physicians. The Northeast Georgia Medical Center & Health System, Inc. designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. If you have technical difficulties or questions contact CME@nghs.com [CME@nghs.com] AMA citations Anzueto A, Barjaktarevic IZ, Siler TM, et al. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials). Am J Respir Crit Care Med. 2023;208(4):406-416. doi:10.1164/rccm.202306-0944OC Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation. N Engl J Med. 2024;390(24):2274-2283. doi:10.1056/NEJMoa2401304 Bhatt SP, Rabe KF, Hanania NA, et al. Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS). Respir Med. 2025;236:107846. doi:10.1016/j.rmed.2024.107846 Sciurba FC, Criner GJ, Christenson SA, et al. Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype. N Engl J Med. 2025;392(17):1710-1720. doi:10.1056/NEJMoa2413181
19 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Northeast Georgia Health System Medical Staff Podcast-Community!